The blacklist of antibiotic resistance threats has been revealed
– WHO’s takes action on the antibiotic resistance crisis
WHO has recently published a list of antibiotic resistant microbes in order to increase focus on a globally growing threat. The list contains 12 families of bacteria, that have acquired multiple resistant to several antibiotics. These organisms pose a great risk to the public health, as they are forcing the use of our last line of antibiotics.
WHO emphasizes the need for serious initiatives to counteract the growth of multi-resistant bacteria and wish to spark research and R&D. To prioritize the initiatives WHO has ranked the bacteria in accordance with their level of threat. A special attention is given to gram-negative bacteria due to their adaptability to resist treatments and ability to pass on genetic material, which allows other bacteria to become resistant too.
Multi-resistant hospital acquired bacteria are the most critical group and therefore should receive the highest priority. The second and the third group, the high and medium priority groups, presents the more common diseases such as gonorrhea and food poisoning caused by Salmonella.
WHO has their main focus on developing new antibiotics, but also conclude that the “public health threats may be addressed by other interventions that could significantly reduce the burden of infections due to antibiotic-resistant bacteria (Publication, global PPL)”.
How Sonosteam contribute to this battle?
To counteract this threat SonoSteam can contribute with hospital mattress disinfection equipment. SonoSteam can also offer disinfection of hospital equipment, e.g. handling equipment like transport boxes. Such solutions contribute to the reduction of multi-resistant bacteria in hospitals and limit the amount of deadly infections due to less cross contamination between patients. SonoSteam can reduce the number of outbreaks and individual cases of sickness caused by lack of food safety, which as well will reduce the need for antibiotic treatment.
The proactive treatment of SonoSteam within hospitals and food manufacturers will consequently reduce the need for antibiotic treatment and thereby slow the growth in multi-resistant bacteria, which causes the need for new types of antibiotics. The development of new antibiotics is expensive and takes a long time to be medically approved. SonoSteam could therefore function as a faster alternative to reduce the critical issue of multi-resistant bacteria while new antibiotics are being developed.